» Articles » PMID: 20031391

New Data Tells Us More About Cancer Incidence in North Africa

Overview
Journal Eur J Cancer
Specialty Oncology
Date 2009 Dec 25
PMID 20031391
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Over the last few years, Cancer Registries in North Africa (Morocco, Algeria, Tunisia, Libya and Egypt) increased in number from one to nine, and now covers 13% of the total regional population. Their data can be considered of good or acceptable quality, according to available indicators. The pattern of risk shown by these Registries is quite unique. The total cancer burden in the North African countries is between one third and one half of what is observed in Europe. The overall incidence rate in men (world age standardised, per 100,000) ranges from 86.3 in Sétif, Algeria, to 156.1 in Garbiah, Egypt. The range is similar in women: from 80.3 in Sétif to 164.0 in Algier, both in Algeria. The case mix and the level of rates are quite homogeneous in the countries considered. The most frequent cancers are the same as in Europe (Lung, Breast and Prostate). This pattern completely differs from that of Central and Southern African countries, where infection-related cancers are predominant. The well-known excess risk for nasopharyngeal carcinoma in this area is confirmed, with rates reaching the level of 5.4 in men and 1.9 in women, which is 10 times higher than that in Europe.

Citing Articles

Cancer statistics in Yemen: incidence and mortality, in 2020.

Ibrahim A, El Baldi M, Mohammed S, El Rhazi K, Benazzouz B BMC Public Health. 2024; 24(1):962.

PMID: 38580993 PMC: 10996160. DOI: 10.1186/s12889-024-18207-4.


Cancer mortality patterns in selected Northern and Southern African countries.

Pizzato M, Santucci C, Parazzini F, Negri E, La Vecchia C Eur J Cancer Prev. 2023; 33(3):192-199.

PMID: 37997906 PMC: 10965137. DOI: 10.1097/CEJ.0000000000000852.


Impact of induction chemotherapy with concurrent chemoradiotherapy on nasopharyngeal carcinoma: A meta-analysis of randomized controlled trials.

Huang T, Chen C, Ding Y, Kang Y Front Oncol. 2022; 12:965719.

PMID: 36176397 PMC: 9513799. DOI: 10.3389/fonc.2022.965719.


Current Opinion and Practice on Peritoneal Carcinomatosis Management: The North African Perspective.

Souadka A, Essangri H, Makni A, Abid M, Ayadi M, Ksantini F Front Surg. 2022; 9:798523.

PMID: 35350143 PMC: 8957835. DOI: 10.3389/fsurg.2022.798523.


Incidence Trends of Cancer in Morocco: The Tale of the Oncological Center of Marrakech (Morocco) over 8 Years.

Belbaraka R, Benhima N, Laatabi A, El Fadli M, Essadi I J Cancer Epidemiol. 2022; 2022:3307194.

PMID: 35265131 PMC: 8901288. DOI: 10.1155/2022/3307194.